Joel R Rosh

Summary

Affiliation: Morristown Memorial Hospital
Country: USA

Publications

  1. ncbi Chronic childhood constipation is associated with impaired quality of life: a case-controlled study
    Nader N Youssef
    Center for Pediatric Functional Gastrointestinal and Motility Disorders, Goryeb Children s Hospital, Atlantic Health System Morristown, New Jersey 07962, USA
    J Pediatr Gastroenterol Nutr 41:56-60. 2005
  2. ncbi Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions
    Nader N Youssef
    Center for Pediatric Functional Gastrointestinal and Motility Disorders, Goryeb Children s Hospital Atlantic Health System, Morristown, NJ 07962, USA
    Pediatrics 117:54-9. 2006
  3. ncbi Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease
    Joel R Rosh
    Division of Pediatric Gastroenterology, Goryeb Children s Hospital Atlantic Health, Morristown, New Jersey 07962, USA
    Am J Gastroenterol 104:3042-9. 2009
  4. ncbi Use of biologic agents in pediatric inflammatory bowel disease
    Joel R Rosh
    Division of Pediatric Gastroenterology, Goryeb Children s Hospital at Atlantic Health, Morristown, New Jersey 07962, USA
    Curr Opin Pediatr 21:646-50. 2009
  5. ncbi Alternative strategies for the use of infliximab in pediatric inflammatory bowel disease
    Joel R Rosh
    Department of Pediatric Gastroenterology, Goryeb Children s Hospital at Atlantic Health, 100 Madison Avenue, Morristown, NJ 07962, USA
    Curr Gastroenterol Rep 10:302-7. 2008
  6. ncbi Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?
    Joel R Rosh
    Goryeb Children s Hospital Atlantic Health, Morristown, New Jersey, USA
    Inflamm Bowel Dis 13:1024-30. 2007
  7. ncbi Celiac crisis in the modern era
    Richard L Mones
    Department of Pediatric Gastroenterology, Goryeb Children's Hospital/Atlantic Health, 100 Madison Ave, Box 82, Morristown, NJ 07962, USA
    J Pediatr Gastroenterol Nutr 45:480-3. 2007
  8. ncbi A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease
    Athos Bousvaros
    Division of Pediatric Gastroenterology, Children s Hospital, Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 11:833-9. 2005
  9. ncbi Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned
    Joel R Rosh
    J Pediatr Gastroenterol Nutr 44:165-7. 2007
  10. ncbi Inflammatory bowel disease in young children
    Joel R Rosh
    Am J Gastroenterol 102:205-6, author reply 206. 2007

Detail Information

Publications10

  1. ncbi Chronic childhood constipation is associated with impaired quality of life: a case-controlled study
    Nader N Youssef
    Center for Pediatric Functional Gastrointestinal and Motility Disorders, Goryeb Children s Hospital, Atlantic Health System Morristown, New Jersey 07962, USA
    J Pediatr Gastroenterol Nutr 41:56-60. 2005
    ..The objective of this study was to investigate the effect of chronic constipation on children's quality of life...
  2. ncbi Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions
    Nader N Youssef
    Center for Pediatric Functional Gastrointestinal and Motility Disorders, Goryeb Children s Hospital Atlantic Health System, Morristown, NJ 07962, USA
    Pediatrics 117:54-9. 2006
    ..The aim of this study was to assess patients' and parents' perceptions of health-related quality of life (QoL) for children with FAP...
  3. ncbi Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease
    Joel R Rosh
    Division of Pediatric Gastroenterology, Goryeb Children s Hospital Atlantic Health, Morristown, New Jersey 07962, USA
    Am J Gastroenterol 104:3042-9. 2009
    ..The aim of this study was to characterize common indications, safety, tolerability, and clinical response to adalimumab in pediatric CD in a large, multicenter, patient cohort...
  4. ncbi Use of biologic agents in pediatric inflammatory bowel disease
    Joel R Rosh
    Division of Pediatric Gastroenterology, Goryeb Children s Hospital at Atlantic Health, Morristown, New Jersey 07962, USA
    Curr Opin Pediatr 21:646-50. 2009
    ..Clinical experience with therapy targeted against tumor necrosis factor-alpha has raised important questions about these agents, which will be addressed in this review...
  5. ncbi Alternative strategies for the use of infliximab in pediatric inflammatory bowel disease
    Joel R Rosh
    Department of Pediatric Gastroenterology, Goryeb Children s Hospital at Atlantic Health, 100 Madison Avenue, Morristown, NJ 07962, USA
    Curr Gastroenterol Rep 10:302-7. 2008
    ..Finally, the optimal placement of infliximab in the algorithm for the medical treatment of pediatric inflammatory bowel disease remains an open question...
  6. ncbi Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?
    Joel R Rosh
    Goryeb Children s Hospital Atlantic Health, Morristown, New Jersey, USA
    Inflamm Bowel Dis 13:1024-30. 2007
    ..Additionally, a description of HSTCL and a summary of the known cases of this apparent therapeutic complication are presented. Clinical options in light of this new information are explored...
  7. ncbi Celiac crisis in the modern era
    Richard L Mones
    Department of Pediatric Gastroenterology, Goryeb Children's Hospital/Atlantic Health, 100 Madison Ave, Box 82, Morristown, NJ 07962, USA
    J Pediatr Gastroenterol Nutr 45:480-3. 2007
  8. ncbi A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease
    Athos Bousvaros
    Division of Pediatric Gastroenterology, Children s Hospital, Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 11:833-9. 2005
    ..18). The LGG was well tolerated, with a side effect profile comparable with placebo. This study suggests that LGG does not prolong time to relapse in children with CD when given as an adjunct to standard therapy...
  9. ncbi Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned
    Joel R Rosh
    J Pediatr Gastroenterol Nutr 44:165-7. 2007
  10. ncbi Inflammatory bowel disease in young children
    Joel R Rosh
    Am J Gastroenterol 102:205-6, author reply 206. 2007